{"id":"W2325083664","doi":"10.1097/hco.0b013e3283605fa2","title":"New therapies to reduce low-density lipoprotein cholesterol","year":2013,"lang":"en","type":"review","venue":"Current Opinion in Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Thomas Hospital","funders":"Regeneron Pharmaceuticals; AstraZeneca; Pfizer; Amgen","keywords":"Medicine; Ezetimibe; PCSK9; Familial hypercholesterolemia; Alirocumab; Proprotein convertase; Evolocumab; Statin; Kexin; Internal medicine; Cholesterylester transfer protein; Cholesterol; Lipoprotein; Endocrinology; Pharmacology; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009062631,0.0007103329,0.004597511,0.0005312139,0.00006447807,0.00003718526,0.0003681022,0.000739435,0.00007716544],"category_scores_gemma":[0.0001561941,0.0005469258,0.001597273,0.0005533469,0.00007050138,0.00006396072,0.0002566786,0.001333887,0.0008572763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004313032,"about_ca_system_score_gemma":0.001121369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005643076,"about_ca_topic_score_gemma":0.000005810499,"domain_scores_codex":[0.9958065,0.000799764,0.001063377,0.001097489,0.0004875766,0.0007453531],"domain_scores_gemma":[0.9973195,0.00007319747,0.0002638951,0.001631309,0.0001390555,0.0005730165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00001807803,0.00003181748,0.00003795139,0.01920206,0.0003317209,0.000006606353,0.00007488488,0.000001122176,6.134285e-7,0.00004148964,0.01341476,0.9668389],"study_design_scores_gemma":[0.0008657757,0.0002113857,0.001260473,0.02441342,0.000254335,0.0005194525,0.00001574857,4.103762e-7,0.000001787973,0.00003768753,0.9719762,0.0004433166],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009067378,0.9822896,0.001006974,0.0002761421,0.01018035,0.005811202,0.00002113181,0.00009493592,0.0002289833],"genre_scores_gemma":[0.0000378024,0.9882353,0.0003770078,0.00006751723,0.009604528,0.001147038,0.000260671,0.0001007267,0.0001694155],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9663956,"threshold_uncertainty_score":0.9999207,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1074865783590459,"score_gpt":0.4014483630650557,"score_spread":0.2939617847060098,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}